Advaxis, Inc. – ‘SB-2/A’ on 4/7/05 – ‘EX-10.14’

On:  Thursday, 4/7/05, at 5:34pm ET   ·   As of:  4/8/05   ·   Private-to-Public:  Document/Exhibit ¶  –  Release Delayed   ·   Accession #:  1144204-5-10850   ·   File #:  333-122504

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Pre-Effective Amendment to Registration of Securities of a Small-Business Issuer   —   Form SB-2
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SB-2/A      Pre-Effective Amendment to Registration of          HTML   1.15M 
                          Securities of a Small-Business Issuer                  
20: COVER     ¶ Comment-Response or Cover Letter to the SEC         HTML    103K 
 2: EX-5.1      Opinion re: Legality                                HTML      6K 
 6: EX-10.10    Material Contract                                      5     20K 
 7: EX-10.11    Material Contract                                      6     26K 
 8: EX-10.12    Material Contract                                   HTML      8K 
 9: EX-10.13    Material Contract                                      9     40K 
10: EX-10.14    Material Contract                                      2     13K 
11: EX-10.15    Material Contract                                      6     26K 
12: EX-10.16    Material Contract                                   HTML     88K 
13: EX-10.20    Material Contract                                      8     33K 
14: EX-10.21    Material Contract                                     14     58K 
15: EX-10.22    Material Contract                                   HTML      7K 
16: EX-10.23    Material Contract                                   HTML      6K 
17: EX-10.24    Material Contract                                   HTML      7K 
18: EX-10.25    Material Contract                                   HTML      7K 
 3: EX-10.7     Material Contract                                   HTML    144K 
 4: EX-10.8     Material Contract                                   HTML      8K 
 5: EX-10.9     Material Contract                                      6     29K 
19: EX-23.1     Consent of Experts or Counsel                       HTML     10K 

‘EX-10.14’   —   Material Contract

EX-10.14
1st Page of 2
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
                                                                   Exhibit 10.14

ADVAXIS, INC
212 CARNEGIE CENTER, SUITE 206
 PRINCETON, NJ 08540
 PHONE: (609) 497-7555
 FAX: (609) 497-9299

                                                         Thursday, June 19, 2003
Eileen G. Gorman, PhD                                                           
DNA Bridges, Inc. ("DNA")                                                       
700 Cheltenham Rd.                                                              
Wilmington, DE 19808-1507                                                       

Dear Eileen,                                                                    

 RE: GRANT WRITING AGREEMENT

This letter summarizes our understanding regarding the terms and conditions of  
the engagement for the purpose of DNA's implementation and execution of a grant 
writing strategy for Advaxis, Inc ("Advaxis" or "Company"):                     

1)    Project:                                                                  

     a)    Implement and execute a grant writing strategy on behalf of Advaxis
 based on the schedule and grants specified in SCHEDULE A.
Specifically:                                           

   2)    Developing and managing proposal development timeline

3)    Gathering relevant background material            

4)    Writing the grant                                 

          5)    Editing grant and working with client to fine tune the grant
application                                 

6)    Preparing budget requirements for grant           

           7)    Prepare forms prior to submission (form review by the company
            must be completed one week prior to the final submission
target date)                                

      8)    All other items reasonably necessary to submit the grant

9)    Payment schedule: As described in SCHEDULE B.                             

10)   Conflict of interest: If a conflict of interest should arise during the   
performance of this Agreement, DNA shall immediately notify Company 
thereof.                                                            

11)   Confidentiality: the terms of the existing confidentiality agreement      
between DNA and Advaxis shall apply.                                

12)   Assignment of Inventions. DNA agrees that DNA will promptly make full     
    written disclosure to Company, will hold in trust for the sole right and
     benefit of Company, and hereby assigns, transfers and conveys to Company,
     or its designee, all of DNA's worldwide right, title, and interest in and
to any and all inventions, original works of authorship, findings,  
 conclusions, data, discoveries, developments, concepts, improvements,
trade secrets, techniques, processes and know-how, whether or not   
    patentable or registrable under copyright or similar laws, which DNA may
    solely or jointly conceive or develop or reduce to practice, or cause to

EX-10.14
Last Page of 2
TOC
1st
Previous
Next
↓Bottom
Just 2nd
   be conceived or developed or reduced to practice, in the performance of
      the services under this agreement or which result, to any extent, from use
of Company's premises or property.                                  

13)   Independent Contractor. For purposes of this Agreement and all Services to
      be provided hereunder, DNA shall not be considered a partner, co-venturer,
 agent, employee or representative of Company, but shall remain in all
      respects an independent contractor, and neither party shall have any right
      or authority to make or undertake any promise, warranty or representation,
to execute any contract, or otherwise to assume any obligation or   
responsibility in the name of or on behalf of the other party.      

14)   Termination: Each party may terminate this agreement with a 30 day prior  
notice.                                                             

15)   Amendment: This Agreement constitutes the entire agreement between the    
     parties with respect to the subject matter hereof. This Agreement may not
     be amended, modified or waived, except in writing signed by both parties.
   Both parties may agree in writing to amend this agreement or any of its
schedules.                                                          

16)   Dispute resolution: Any dispute that arises in connection with agreement  
     shall be determined by arbitration conducted in Princeton, New Jersey, in
accordance with the Commercial Arbitration Rules of the American    
Arbitration Association then existing.                              

IN WITNESS HEREOF, the parties have read and agree to be bound by the above     
terms and conditions and have entered into this Agreement effective as of the   
date set forth above.                                                           

ADVAXIS, INC                               DNA BRIDGES, INC                     

Signature:  /s/ J. Todd Derbin             Signature:  /s/ Eileen Gorman        
            -------------------------                  -------------------------
Name                                       Name:       Eileen Gorman            
Title:                                     Title:                               
                            EIN#:       54-1957384

Date:                                      Date:                                
            -------------------------            -------------------------------

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘SB-2/A’ Filing		Date		First		Last			Other Filings
Filed as of:		4/8/05
Filed on:		4/7/05							8-K/A
		6/19/03		1
									List all Filings